We are looking for children and teenagers 2–17 years of age to join a Crohn’s disease (CD) clinical trial to help us discover more about treating moderate to severe CD. If you are looking for a potential new treatment option for moderate to severe CD or Crohn’s disease (including associated symptoms such as rectal bleeding, joint pain, abdominal pain, chronic fatigue and/or canker sores), consider one of our GI research studies. All eligible participants will receive no-cost study-related care and study medication. Your children and teenagers 2–17 years of age may be eligible to take part.
Your child may be eligible to take part in the GI research studies if they:
- are 2‒17 years of age
- have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
- have previously received treatment for UC or CD that has not worked.
Enrolling for a limited time.
